Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000667783 | SCV000792287 | pathogenic | Fanconi anemia complementation group A | 2017-06-14 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000731876 | SCV000859739 | pathogenic | not provided | 2018-02-19 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001218261 | SCV001390135 | pathogenic | Fanconi anemia | 2023-12-27 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Thr1375Serfs*49) in the FANCA gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 81 amino acid(s) of the FANCA protein. This variant is present in population databases (rs776969626, gnomAD 0.006%). This premature translational stop signal has been observed in individuals with Fanconi anemia (PMID: 21273304, 23934222, 27041517). ClinVar contains an entry for this variant (Variation ID: 552509). This variant disrupts the p.Arg1400 amino acid residue in FANCA. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 15643609, 21273304, 24584348, 28102861, 28717661, 29098742). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV000731876 | SCV003919630 | likely pathogenic | not provided | 2022-10-24 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation, as the last 81 amino acids are replaced with 48 different amino acids, and other loss-of-function variants have been reported downstream in HGMD; This variant is associated with the following publications: (PMID: 31589614, 24037726, 30792206, 28717661, 27041517, 21273304, 23934222, 26366677) |
Baylor Genetics | RCV000667783 | SCV004196048 | pathogenic | Fanconi anemia complementation group A | 2023-08-26 | criteria provided, single submitter | clinical testing | |
Leiden Open Variation Database | RCV000667783 | SCV001425864 | pathogenic | Fanconi anemia complementation group A | 2020-02-28 | no assertion criteria provided | curation | Curator: Arleen D. Auerbach. Submitters to LOVD: Arleen D. Auerbach, Daniela Pilonetto. |
Natera, |
RCV001218261 | SCV002092472 | pathogenic | Fanconi anemia | 2020-02-07 | no assertion criteria provided | clinical testing |